ICT U.S.-Inheritor Cell Technology (USA) Inc. is a biotechnology company specializing in the research and the clinical application of stem cells. The company owns two modern research centers: the North American Regenerative Medicine Research Center and the China Clinical Application Center; both grand in scale and up to GMP standard. The American Center focuses on basic research, while the China Center focuses on clinical practice. The company has also established 80,000-sq-ft biobank (clinical-grade) in the Los Angeles area. ICT prides itself as multinational and one of the few pioneers within the regenerative medicine field with dual medical centers.

  • HR@ictcells.com

ICT U.S. Current Open Positions